about
The emerging role of miR-506 in cancerAn overview of long non-coding RNAs in ovarian cancersMicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune ResponseDouble-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeIn-silico modeling of granulomatous diseasesCell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcomamiR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expressionLowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-RafEvaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.The RNA-centred view of the synapse: non-coding RNAs and synaptic plasticityMicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancerThe potential of microRNAs in personalized medicine against cancers.miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells.Effects of preanalytic variables on circulating microRNAs in whole blood.Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a.miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles.Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.Biomarkers in neonatology: the new "omics" of bronchopulmonary dysplasia.Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth.MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.Aberrant DNA Methylation: Implications in Racial Health Disparity.MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomasCirculating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.Small molecules targeting microRNA for cancer therapy: Promises and obstacles.MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progressionTargeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesTransient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.Identification of microRNAs dysregulated in cellular senescence driven by endogenous genotoxic stress.From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients.Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
P2860
Q26740283-C21BEC20-8B1A-48D0-9454-EA9AA564CD12Q26753467-E76A3BE7-5021-436A-9D1E-397EDDAAB0AAQ26798503-0BB304CC-1EEA-49D7-8C22-556B9408395CQ28271788-A2C5270D-BFEB-46C0-9F0E-F224D5F9F7D8Q28392685-FCFAB829-A535-4A41-ADCC-DB0E3DF0805AQ28485302-A85071D1-1860-46A5-AFD7-4C527DDDA870Q28485384-8EE8CE8A-F701-43F6-BA28-292A12CF5CBCQ33648849-321AF446-12B8-4A9F-8A19-D50EA2880C31Q33747550-994B34FD-43D8-49F8-BFF8-A7812E7F8803Q34049716-9C8495A9-4304-4964-AD8E-667595E64A15Q34079393-3F601E45-68B9-468B-BA59-9B89740631C0Q34093798-9FB923F0-FC42-41ED-86AA-0B1EF774FFE8Q34177547-B8A0D90D-53E8-4DBC-92E9-1009FE612A29Q34477328-968A264A-3CF7-493E-83FD-BA4E8584A55AQ34526886-3A7FC38F-DAA6-4540-9CFB-494F2A9061D2Q34635975-E88E8384-9AAE-4A6C-A4AE-7D56D99073BCQ34764114-40895A2D-4D78-4CDA-92DF-3E0C5C2A4691Q34981651-B1F5EC15-5E77-4DB6-A2F3-D3FB7D59C210Q35293772-D7B3578F-E848-405A-AD6D-C4220A6302C0Q35546267-4AEF1BFC-E7E4-4167-9206-9732AB379050Q35571226-B78326CC-8C05-4409-BED9-35EBA5CCCC26Q35681161-93AD48FE-8008-46CB-BA93-2254EC27EA18Q35829861-38C22C6E-DC1A-4C71-AC88-45DB90089902Q35923419-8743B9C5-7EB4-48BC-B2CA-9A52A45BBA31Q35998173-EC430A81-8B76-45BC-9CF8-3F06D39DE2CBQ36159870-E25F90BD-9DC2-40A9-8FDA-235F4049F369Q36253066-7F294C90-106B-4BDC-9D58-0D4C45D7B57FQ36382323-500A8CC5-DBEE-4308-B44A-A021AEE414E3Q36545005-C8495ED5-566C-459A-B8FF-970074BB6339Q36567511-C3C0BEB1-9CEA-43A7-8723-7D59A76FCB5CQ36615420-7DAEF0E3-D131-433F-B27B-26B03FB2A478Q36738971-53E5D295-54D9-4E68-985C-E1FA97325364Q37057240-31166BD5-128F-4A99-B357-C04436C32C46Q37080584-C4540B2B-ECC0-4F52-AF48-8881A9E1693FQ37158033-2577CE98-43FF-4A42-9BF4-EA7429050A71Q37246484-0C25F248-9F13-4CFD-AFA5-3F6399F5230BQ37298895-6A1FE4F9-F3DA-43B9-ABDE-0C324EB826ACQ37313310-DF655B48-6B18-47B9-8CF1-9D20C7254B1AQ37444430-116B26CE-E6E3-49D7-83F8-BF3E2B2D2827Q37642555-F4AC80F1-1A74-4629-94A7-A887489A0F2C
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Causes and consequences of microRNA dysregulation
@ast
Causes and consequences of microRNA dysregulation
@en
type
label
Causes and consequences of microRNA dysregulation
@ast
Causes and consequences of microRNA dysregulation
@en
prefLabel
Causes and consequences of microRNA dysregulation
@ast
Causes and consequences of microRNA dysregulation
@en
P2860
P1433
P1476
Causes and consequences of microRNA dysregulation
@en
P2093
Marilena V Iorio
P2860
P304
P356
10.1097/PPO.0B013E318250C001
P577
2012-05-01T00:00:00Z